Drug intelligence / Profile preview

Mouskito

Development stage
Unknown
Lead developer
Qualiphar
Modality
Small Molecules
Administration
Topical
01

Overview

Mouskito is a line of over-the-counter (OTC) insect repellent products developed and marketed by the Belgian healthcare company Qualiphar. The product range is designed to provide protection against a variety of biting insects, including mosquitoes, ticks, and flies, which are vectors for diseases such as malaria, dengue fever, Zika virus, and Lyme disease. The Mouskito portfolio includes several formulations tailored for different needs: Mouskito Tropical (containing 50% DEET), Mouskito Family and Junior (utilizing Icaridin/Picaridin), and Mouskito Natural (based on Citriodiol/Eucalyptus citriodora oil). These active ingredients function by disrupting the insect's olfactory and gustatory receptors, effectively masking human attractants or acting as a deterrent to prevent landing and biting. The products are available in various topical formats, including sprays, lotions, and sticks, and are approved for use in both temperate and tropical environments.

Brand names
Mouskito
02

Targets

OR (Olfactory receptors)

Beyond the preview

Go deeper on Mouskito.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mouskito.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call